Literature DB >> 19515877

Quality of life after mechanical vs. biological aortic valve replacement.

Anas Aboud1, Martin Breuer, Torsten Bossert, Jan F Gummert.   

Abstract

To assess the quality of life after biological and mechanical aortic valve replacement, data of 136 patients were assessed retrospectively after 2 years of follow-up. Bioprostheses were implanted in 53 patients with a mean age of 74 years, and mechanical prostheses were used in 83 with a mean age of 64 years; there were 47 women and 89 men. Quality of life was evaluated using the Short Form 36-Item Health Survey questionnaire. Physical function scores were significantly better in patients with a mechanical prosthesis. Mental health indices were identical in both groups. Younger patients with mechanical valves and older patients with biological valves had significantly better item scores. In all age groups, men tended to have better scores than women, but a significant difference was noted only in the physical functioning index. The quality of life in patients with mechanical and biological valves was similar at 2 years postoperatively.

Entities:  

Mesh:

Year:  2009        PMID: 19515877     DOI: 10.1177/0218492309102522

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  3 in total

1.  A systematic review of the cost-effectiveness of heart valve replacement with a mechanical versus biological prosthesis in patients with heart valvular disease.

Authors:  Samad Azari; Aziz Rezapour; Negar Omidi; Vahid Alipour; Masih Tajdini; Saeed Sadeghian; Nicola Luigi Bragazzi
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

2.  Stented bioprostheses in aortic position.

Authors:  J Cremer; J Schöttler; R Petzina; G Hoffmann
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

Review 3.  Does quality of life improve in octogenarians following cardiac surgery? A systematic review.

Authors:  Udo Abah; Mike Dunne; Andrew Cook; Stephen Hoole; Carol Brayne; Luke Vale; Stephen Large
Journal:  BMJ Open       Date:  2015-04-28       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.